Skip to main content
FAQs
Glossary
Close
FAQs
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?
See all FAQs
Close
Glossary
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial
See full Glossary
EuroGCT
Menu
Close
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Main navigation
Discover
Discover
Discover Gene and Cell Therapy
Educational Resources Directory
Educational Resources Directory
INTENS
INtestinal Tissue ENgineering Solution
LEARN
Listening to the experience of participants in neurosurgical trials
Discover Gene and Cell Therapy
Research Pathways
Research Pathways
Bringing new therapies from the lab to patients
EuroGCT Key Resources
EuroGCT Key Resources
ATMP Engage
Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
Actors and Network database
Actors and Network database
Bringing new therapies from the lab to patients
About Us
Our team and partners
Contact
Condition
Alzheimer's Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Cord Blood
Cystic Fibrosis
Diabetes
Epidermolysis Bullosa
Eye Disease
Heart Disease
Huntington's Disease
Immune Conditions
Kidney Disease
Liver Disease
Lung Disease
Motor Neurone Disease
Multiple Sclerosis
Muscle and Skeletal Diseases
Muscular Dystrophy
Neurological Disorders
Parkinson's Disease
Rare Diseases
Sickle Cell Disease
Skin
Spinal Cord Injuries
Spinal Muscular Atrophy
Stroke
Reproduction and Fertility
Theme
Blood Stem Cells
CAR-T Therapy
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Cord Blood
Current and Potential Uses
Disease Modelling
Embryonic Stem Cells
Ethics and Society
Explore Stem Cells
Factsheets
Gene Editing
Gene Therapy
Industry
iPS cells
Methods and Tools
MSCs
Organoids
Patient Involvement
Policy & Regulation
Reprogramming
Research
Skin Stem Cells
Stem Cell News
Tissue Engineering
Unproven Treatments
Search
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Breadcrumb
Home
Resources
Resources
Search within the page or choose from the most common topics below
Theme
Stem Cell News
Current and Potential Uses
Research
Cell and Gene Fundamentals
Blood Stem Cells
CAR-T Therapy
Cell Therapy
iPS cells
Skin Stem Cells
Embryonic Stem Cells
MSCs
Clinical Trials
Patient Involvement
Cord Blood
Explore Stem Cells
Disease Modelling
Gene Editing
Tissue Engineering
Ethics and Society
Factsheets
Gene Therapy
Industry
Policy & Regulation
Unproven Treatments
Methods and Tools
Organoids
Reprogramming
Condition
Stroke
Alzheimer's Disease
Spinal Muscular Atrophy
Eye Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Immune Conditions
Kidney Disease
Neurological Disorders
Lung Disease
Rare Diseases
Heart Disease
Muscle and Skeletal Diseases
Liver Disease
Cord Blood
Diabetes
Cystic Fibrosis
Muscular Dystrophy
Epidermolysis Bullosa
Multiple Sclerosis
Skin
Spinal Cord Injuries
Sickle Cell Disease
Reproduction and Fertility
Search by keyword
EuroGCT Resource
[Poster] The challenges of Advanced Therapy Medicinal Products manufacturing in the European Union: Strengths and limits of current regulatory tools
EuroGCT Resource
Why are some conditions more suitable for gene and cell therapies than others?
Related Topics
Cell Therapy
Clinical Trials
Current and Potential Uses
Disease Modelling
Ethics and Society
Gene Editing
Gene Therapy
Methods and Tools
Patient Involvement
Policy & Regulation
Research
EuroGCT Resource
Where should I start?
Related Topics
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Current and Potential Uses
Ethics and Society
Gene Therapy
Methods and Tools
Patient Involvement
Policy & Regulation
Research
EMA certification procedures for SMEs
English
EuroGCT Resource
Using 'reprogrammed' cells to model diseases
Related Topics
Current and Potential Uses
Disease Modelling
iPS cells
Methods and Tools
Organoids
Reprogramming
Tissue Engineering
EuroGCT Resource
There is an approved treatment available for my condition - why can't I receive it?
Related Topics
Rare Diseases
Clinical Trials
Current and Potential Uses
Ethics and Society
Industry
Policy & Regulation
Unproven Treatments
ATTC Advanced Therapies NHS Readiness Toolkit
EMA Resource: Journey of a Medicine
English
Sickle Cell DIsease (SCD) and Stem Cell Transplant
Related Topics
Sickle Cell Disease
English
Sickle cell and stem cell transplant
Related Topics
Sickle Cell Disease
Inheritance patterns
Related Topics
Cell and Gene Fundamentals
English
MS Ireland: MS and Stem Cells
Related Topics
Immune Conditions
Multiple Sclerosis
Neurological Disorders
Current and Potential Uses
Patient Involvement
Genomics For Educators
Emily's Entourage: CF Clinical Trials Connect
Related Topics
Cystic Fibrosis
Clinical Trials
Patient Involvement
Research
CF Trust: Cystic Fibrosis Trials Tracker
Related Topics
Cystic Fibrosis
Clinical Trials
Patient Involvement
Research
Human genetic variation and disease
English
Growing support for gene and cell therapies in Germany
Related Topics
Cell Therapy
Ethics and Society
Gene Therapy
Policy & Regulation
English
The role of stem cell models in drug repurposing: Researcher Ole Pless in portrait
Related Topics
Rare Diseases
Research
English
Stem cell therapies against diabetes: Portrait of researcher Maike Sander
Related Topics
Diabetes
Organoids
Research
Relevant Literature section of EuroGCT’s key resources
Pagination
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »
Back to top
